AB0460 INTERLEUKIN-6 INHIBITION WITH TOCILIZUMAB FOR THE TREATMENT OF GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA IN PATIENTS WITH SERIOUS COMORBIDITIES
Sign Up to like & getrecommendations! Published in 2020 at "Annals of the Rheumatic Diseases"
DOI: 10.1136/annrheumdis-2020-eular.2179
Abstract: Giant cell arteritis (GCA) and polymyalgia rheumatica (PMR) are closely related inflammatory conditions affecting people aged over 50 years.We present our experience of using tocilizumab (TCZ) therapy for management of GCA/PMR aggravated by severe concurrent… read more here.
Keywords: cell arteritis; giant cell; treatment; gca pmr ... See more keywords
Long-Term Results of a Phase 2 Study of Definitive Chemoradiation Therapy Using S-1 for Esophageal Squamous Cell Carcinoma Patients Who Were Elderly or With Serious Comorbidities
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.839765
Abstract: Background The optimal evidence-based management for the subsets of locally advanced esophageal squamous cell carcinoma (ESCC) patients who rejected or were intolerant to intravenous chemotherapy due to old age or serious comorbidities is currently lacking.… read more here.
Keywords: escc patients; cell carcinoma; serious comorbidities; squamous cell ... See more keywords